Clinical Trial Update: Raltegravir as Early Therapy in African-Americans Living With HIV Study [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update on raltegravir as early therapy in African-Americans with HIV infection. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: David A Wohl, MD | Conditions: HIV Infections | Phase 1 | Status: COMPLETED